Atlas Trials

Evaluate the Quality of Life and Treatment of Anxiety Symptoms of Buspirone in Patients With Depression Disorders(BASIS)

Clinical trial NCT04770454 · COMPLETED

Trial details

NCT number
NCT04770454
Sponsor
Boryung Pharmaceutical Co., Ltd
Status
COMPLETED
Study type
OBSERVATIONAL
Depressive Disorder, MajorAnxiety Disorders
Start date
2021-02-08
Primary completion
2023-03-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.